doi:10.3969/j.issn.1004-583X.2025.01.013

Abstract

CLC Number:

R631

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2025.01.013

https://huicui.hebmu.edu.cn/EN/Y2025/V40/I1/82

References 30

[1]	陈芳, 祝益民. 脓毒症与脓毒性休克的诊治策略[J]. 实用休克杂志(中英文), 2022, 6(4):193-194+207.
[2]	Landoni G, Cortegiani A, Bignami E, et al. The use of angiotensin II for the management of distributive shock: Expert consensus statements[J]. J Anesth Analg Crit Care, 2024, 4(1):56.
[3]	Ali R, Sajjad W, Mushtaq I, et al. Unlocking the therapeutic symphony: A systematic review exploring the role of levosimendan in the management of heart failure[J]. Cureus, 2024, 16(6):e62799.
[4]	Mukherjee V, Evans L. Implementation of the surviving sepsis campaign guidelines[J]. Curr Opin Crit Care, 2017, 23(5):412-416. doi: 10.1097/MCC.0000000000000438 pmid: 28858918
[5]	He B, Wang X, Shi L, et al. Meta-analysis of initial natriuretic peptides in the setting of sepsis-induced myocardial dysfunction[J]. Biomark Med, 2024, 18(4):145-155.
[6]	Sanfilippo F, Corredor C, Fletcher N, et al. Diastolic dysfunction and mortality in septic patients:A systematic review and meta-analysis[J]. Intensive Care Med, 2015, 41(6):1004-1013. doi: 10.1007/s00134-015-3748-7 pmid: 25800584
[7]	Hao Y, Liu R, Wang H, et al. Research progress on mechanisms and treatment of sepsis-induced myocardial dysfunction[J]. Int J Gen Med, 2024, 17:3387-3393. doi: 10.2147/IJGM.S472846 pmid: 39130486
[8]	Knappskog K, Andersen NG, Guttormsen AB, et al. Vasoactive and/or inotropic drugs in initial resuscitation of burn injuries: A systematic review[J]. Acta Anaesthesiol Scand, 2022, 66(7):795-802. doi: 10.1111/aas.14095 pmid: 35583993
[9]	Sun T, Zhang N, Cui N, et al. Efficacy of levosimendan in the treatment of patients with severe septic cardiomyopathy[J]. J Cardiothorac Vasc Anesth, 2023, 37(3):344-349.
[10]	Liu DH, Ning YL, Lei YY, et al. Levosimendan versus dobutamine for sepsis-induced cardiac dysfunction: A systematic review and meta-analysis[J]. Sci Rep, 2021, 11(1):20333.
[11]	Guan Q, Zhang C, Li B, et al. Meta-analysis of the efficacy of levosimendan in the treatment of severe sepsis complicated with septic cardiomyopathy[J]. Heart Surg Forum, 2023, 26(5):E609-E620. doi: 10.59958/hsf.6439 pmid: 37920078
[12]	张造章, 陈向红, 马晓杰. 左西孟旦联合重组人脑利钠肽用于难治性心力衰竭患者治疗心功能、炎症反应及血清NT-pro BNP改善价值研究[J]. 中华保健医学杂志, 2023, 25(4):375-378.
[13]	冯俊波, 王亚朋, 胡运涛, 等. 左西孟旦对体外循环肺损伤保护作用的研究进展[J]. 临床肺科杂志, 2021, 26(10):1581-1585.
[14]	Nieminen MS, Fruhwald S, Heunks LM. et al. Levosimendan:Currentdata,clinicaluse and future development[J]. Heart Lung Vessel, 2013, 5(4):227-245.
[15]	贾琳琳. 左西孟旦联合新活素对脓毒性心肌病患者血清脓毒症标志物及血流动力学指标的影响[J]. 中国现代医药杂志, 2024, 26(1):51-54. doi: 10.3969/j.issn.1672-9463.2024.01.011
[16]	Meng JB, Hu MH, Lai ZZ, et al. Levosimendan versus dobutamine in myocardial injury patients with septic shock: A randomized controlled trial[J]. Med Sci Monit, 2016, 22(3):1486-1496.
[17]	田文龙, 程红颖, 董士民. 左西孟旦治疗严重脓毒症及脓毒症休克的临床疗效的Meta分析[J]. 临床荟萃, 2018, 33(7):562-567.
[18]	于晓东, 任晓艺, 刘美霞. 左西孟旦应用于机体重要器官疾病的研究进展[J]. 临床荟萃, 2023, 38(6):573-576.
[19]	Gordon AC, Perkins GD, Singer M, et al. Levosimendan for the prevention of acute organ dysfunction in sepsis[J]. N Engl J Med, 2016, 375(17):1638-1648.
[20]	Lapere M, Rega F, Rex S. Levosimendan in paediatric cardiac anaesthesiology: A systematic review and meta-analysis[J]. Eur J Anaesthesiol, 2022, 39(8):646-655. doi: 10.1097/EJA.0000000000001711 pmid: 35792892
[21]	Wang X, Ma S, Liu Y, et al. Effects and mechanism analysis of combined infusion by levosimendan and vasopressin on acute lung injury in rats septic shock[J]. Cell Biochem Biophys, 2014, 70(3):1639-1645. doi: 10.1007/s12013-014-0107-1 pmid: 25002345
[22]	Zangrillo A, Putzu A, Monaco F, et al. Levosimendan reduces mortality in patients with severe sepsis and septic shock: A meta-analysis of randomized trials[J]. J Crit Care, 2015, 30(5):908-913. doi: 10.1016/j.jcrc.2015.05.017 pmid: 26093802
[23]	Parissis JT, Andreadou I, Bistola V, et al. Novel biologic mechanisms of levosimendan and its effect on the failing heart[J]. Expert Opin Investig Drugs, 2008, 17(8):1143-1150.
[24]	Wang Q, Yokoo H, Takashina M, et al. Anti-inflammatory profile of levosimendan in cecal ligation-Induced septic mice and in lipopolysaccharide-stimulated macrophages.[J]. Crit Care Med, 2015, 43(11):e508-e520.
[25]	陈杰, 邸高正, 于静泊, 等. 左西孟旦在神经系统疾病中的神经保护作用研究进展[J]. 实用休克杂志(中英文), 2023, 7(2):104-108, 126.
[26]	河北省医学会超声分会, 河北省医师协会超声医师分会, 河北省超声医学质量管理与控制中心, 等. 急性呼吸困难床旁肺超声诊断规范专家建议[J]. 疑难病杂志, 2024, 23(3):257-265.
[27]	Wang X, Zhao XZ, Wang XW, et al. Effect of levosimendan on ventricular remodelling in patients with left ventricular systolic dysfunction: A meta-analysis[J]. ESC Heart Fail, 2024, 11(3):1352-1376.
[28]	Thorlacius EM, Wåhlander H, Ojala T, et al. Levosimendan versus milrinone for inotropic support in pediatric cardiac surgery: Results from a randomized trial[J]. J Cardiothorac Vasc Anesth, 2020, 34(8):2072-2080. doi: S1053-0770(20)30185-3 pmid: 32201198
[29]	赵鹤龄, 任珊. 危重型新型冠状病毒肺炎救治:注重并发症和基础病的防治[J]. 实用休克杂志(中英文), 2020, 4(2): 71-74.
[30]	赵浩天, 任珊, 刘奕, 等. 超声医师与重症医师联合急会诊模式对急性呼吸循环衰竭患者的诊疗研究[J]. 中国超声医学杂志, 2024, 40(3):257-260.

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 30

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	. [J]. Clinical Focus, 2024, 39(1): 70-74.
[2]	Tang Aijun, Wang Liwei. Predictive values of platelet count and coagulation index in the 28-day survival of sepsis patients [J]. Clinical Focus, 2023, 38(3): 250-254.
[3]	Zhou Bin, Zeng Cizheng, Huang Yuge, Zhong Mianling, Wu Jiayuan. Effect of pSOFA score combined with C-reactive protein and procalcitonin in prognosis assessment of sepsis children [J]. Clinical Focus, 2022, 37(7): 616-622.
[4]	Zhang Mengyuan, Zhu Yong. Predictive value of procalcitonin clearance and SOFA score on the prognosis of patients with severe sepsis [J]. Clinical Focus, 2022, 37(3): 225-229.
[5]	Xiao Liuniu, Zhong Yanxia, Li Shusheng. Effect of extracorporeal hemopurification for clinical prognosis and cytokine levels of septic: A meta-analysis [J]. Clinical Focus, 2022, 37(1): 5-13.
[6]	. [J]. Clinical Focus, 2021, 36(10): 946-950.
[7]	Hou Wei, Zhang Lijun, Zhang Man, Wang Yakun, Jia Meixuan, Tian Liyuan. Clinical analysis in 84 children with the sepsis of non-elevated peripheral blood leukocytes [J]. Clinical Focus, 2021, 36(9): 799-802.
[8]	Jia Yajie, Yao Ming. Effect of limited and open fluid resuscitation on respiratory mechanics and oxygen metabolism in septic shock patients [J]. Clinical Focus, 2021, 36(9): 803-806.
[9]	Dong Hong, Zhang Huizhi,Qian Qinjuan. Change of Tregs cells percentage, interferon-γ, interleukin-4 and CD25 level in sepsis patients of intensive care unit [J]. Clinical Focus, 2016, 31(1): 63-67.
[10]	Lu Chengxiang;Sun Dejun;Qiu Ting. Role of lactate clearance in evaluation of therapeutic efficacy and prognosis of severe sepsis and septic shock caused by infectious wounds [J]. Clinical Focus, 2015, 30(10): 1152-1155.
[11]	. [J]. Clinical Focus, 2015, 30(4): 468-471.
[12]	PENG Huan-qing;PENG Zhi-yun;FAN Zhi-yong;TANG Zhong-xiang;LIN Hui-wen;LI Feng-hui;WANG Ying-jing. Influence of ulinastatin on von Willebrand factor and thrombomodulin in patients with sepsis [J]. Clinical Focus, 2014, 29(9): 1012-1.0141e+007.
[13]	WANG Xia;TONG Fei;CHEN Hui;HUO Shu-hua;LIU Fang;LIU Zhi-kuan;ZHANG Man-li;ZHAO Kun;LIU Fu-rong. Clinical effect of ω-3 polyunsaturated fatty acid on patients with abdominal sepsis [J]. Clinical Focus, 2014, 29(5): 502-504508.
[14]	BI De-fei;ZHAO Lei;QIAN Feng-hua;QIAN Yi-ming;XI Yao. Diagnosis value of urine N-acetyl-β-D-glocosaminidase on early renal impairment in sepsis patients [J]. CLINICAL FOCUS, 2014, 29(3): 315-317.
[15]	. [J]. CLINICAL FOCUS, 2013, 28(10): 1161-1163.